Peter Wehrwein

PBMs Make a Case for the GLP-1 Teeter Totter: Up on the Pharmacy Benefit, Down on the Medical One | AMCP Nexus 2025

Selling Direct

What Health Plans Should Ask For in Their PBM Contracts If They Want Transparency | AMCP Nexus 2025

Cigna Announces ‘Rebate-Free’ Pharmacy Benefit Model Starting in 2027

Biologic Use in Pediatric Atopic Dermatitis | Fall Clinical Derm 2025

AI in Ophthalmology: The Key to the Present Success Includes a CPT Code. The Future? Agentic AI That Doesn’t Wait To Be Told What To Do | AAO 2025

Researchers say ophthalmologists and optometrists were motivated, at least in part, to use the sutureless grafts for dry eye disease by the profit margin they make on devices.

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

In the Eye of the Beholder: Mixed Results From Study of the Risks of Atropine Drops for Myopia in Children